Faculty
David T. Rubin, MD, FACG, AGAF, FACP, FASGE Joseph B. Kirsner Professor of Medicine Section Chief, Gastroenterology, Hepatology and Nutrition Co-Director, Digestive Diseases Center University of Chicago Medicine Chicago, IL | ||
Bruce E. Sands, MD, MS Dr. Burrill B. Crohn Professor of Medicine Chief of the Dr. Henry D. Janowitz Division of Gastroenterology Icahn School of Medicine at Mount Sinai System Chief, Division of Gastroenterology Mount Sinai Health System New York, NY |
Statement of Need
To provide the best care for your Crohn's disease (CD), guidelines for treatment and monitoring have been designed for gastroenterology care teams. As a patient and advocate of your care, it is important to have knowledge regarding how the guidelines are developed, be aware of the research behind them, and understand how they apply to you as a patient.
Join this webcast, ask the renowned CD specialists your questions during LIVE Q&A, and learn how to:
- Recognize the importance of practice guidelines and how they apply to CD.
- Establish long-term treatment goals to heal the inflamed bowels instead of masking the symptoms.
- Identify key markers of inflammation in CD and how they are used in practice.
- Evaluate the risk of colorectal cancer and colostomy in CD.
- Engage with your CD doctor to discuss your disease and strategies to establish and maintain clinical remission.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Target Audience
Individuals with Crohn's disease
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Rubin reports that he receives grants from AbbVie Inc.; Genentech, Inc./Roche; Janssen Pharmaceuticals, Inc.; Prometheus Laboratories Inc.; Shire; and Takeda Pharmaceuticals U.S.A., Inc. He is a consultant for AbbVie Inc.; AbGenomics; Allergan; Arena Pharmaceuticals, Inc.; Biomica; Bristol-Myers Squibb Company; Dizal Pharmaceutical; Eli Lilly and Company; Ferring Pharmaceuticals Inc.; Genentech, Inc./Roche; Janssen Pharmaceuticals, Inc.; Medtronic; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Pfizer Inc.; Shire; Takeda Pharmaceuticals U.S.A., Inc.; and TARGET PharmaSolutions, Inc. He receives other financial or material support as a member of the Board of Trustees for the American College of Gastroenterology; as Co-Founder, CFO of Cornerstones Health, Inc. (non-profit); and as Co-Founder of GoDuRn, LLC.
Dr. Sands reports he is a consultant for AbbVie Inc.; Allergan; AstraZeneca; Boehringer Ingelheim; Boston Pharmaceuticals; Capella Bioscience; Celltrion Healthcare Co., Ltd; Eli Lilly and Company; Genentech, Inc.; Hoffmann-La Roche AG; Janssen Pharmaceuticals, Inc.; Morphic Therapeutic; Oppilan Pharma Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Progenity, Inc.; Prometheus Laboratories Inc.; Salix Pharmaceuticals; Shire; Takeda Pharmaceuticals U.S.A., Inc.; TARGET PharmaSolutions, Inc.; Theravance Biopharma; and Vivelix Pharmaceuticals. He receives research support from Theravance Biopharma (payment is made to his institution). He is on the advisory committee for Arena Pharmaceuticals, Inc. and Ironwood Pharmaceuticals, Inc.
Olga Askinazi, PhD (planning committee) has no disclosures to report.
Susan Perry (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS(877.263.7767).
TV-107-121219-20